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Abstract 
A patient is described who presented with focal brain lesion considered to be a tumor and 
later developed disseminated white matter disease. After 21 years of clinical and MRI follow 
up, the diagnosis of isolated neurosarcoidosis was confirmed by histology. The follow up of 
more than 21 years in this patient supported the existence of isolated neurosarcoidosis as a 
separate disease entity. 
 
Introduction 
The prevalence of clinical involvement of the nervous system in sarcoidosis is estimated to 
5%-15%, and very rarely it may selectively involve the nervous system (1). We describe a 
patient who presented with focal lesion considered to be a tumor and later developed 
disseminated white matter disease. After 21 years of clinical and MRI follow up, the 
diagnosis of isolated neurosarcoidosis was verified by histology.   
 
Case Report 
In February 1986, a 19-year-old female patient presented with partial motor seizure on the 
right limbs followed by tonic-clonic grand mal seizure for the first time in her life. Neurologic 
examination revealed right upper quadrantanopsia, right hypoesthesia and brisk reflexes on 
the right extremities. Brain CT scan revealed a tumor mass in the left parietal lobe, digital 
subtraction angiography was normal, and the patient was scheduled for biopsy. Laboratory 
examination was normal, except for mildly elevated erythrocyte sedimentation rate (ESR). 
Brain MRI revealed a mass lesion in the left temporal lobe, surrounded with edema without 
gadolinium enhancement (Figure 1a). Biopsy specimen revealed granulomatous inflammation 
in both meninges and white matter, so the diagnosis of tuberculous meningoencephalitis was 
suspected and antituberculotic treatment was started for the next year. The patient denied any 
contacts with tuberculosis and tuberculin test was not performed. She had no new symptoms 
in the next four years; then she developed right-sided hemiparesis and right homonymous 
hemianopsia again. In August 1990, brain MRI revealed extensive white matter 
hyperintensities on T2 and FLAIR sequences, again without gadolinium enhancement (Figure 
1b). Repeat laboratory examination showed mildly elevated ESR. Cerebrospinal fluid (CSF) 
examination revealed 60 lymphocytes, with normal protein and glucose level. Chest x-ray was 
normal. CSF cultures for Mycobacterium tuberculosis and CSF serology for fungi, parasites, 
herpes simplex virus (HSV) and toxoplasmosis were negative. She had control brain MRI 
every year, which showed progression of the lesions (Figure 1 c-l). Despite radiological 
worsening, the patient was clinically well, reporting occasional headaches and vertigo. In this 
period, she did not receive corticosteroid therapy. In 1996, brain MRI showed progression of 
the lesions and CSF examination was repeated to reveal 2 cells, slightly elevated protein level 
(0.54 g/L) and positive oligoclonal bands. Repeat cultures for Mycobacterium and CSF 
serology for Borrelia and HSV were negative. Revision of the brain biopsy specimen 
obtained at the beginning of the disease (Figure 2) was compatible with the diagnosis of 
neurosarcoidosis. Repeat laboratory examination revealed elevated ESR of 34 mm/h, and 
elevated serum ACE of 67. CSF ACE was not performed. Serum calcium, ANF, ENA, 
ANCA, anticardiolipin antibodies, abdominal ultrasound and chest CT scan were normal. 
Total body gallium scintigraphy was normal. Corticosteroid therapy was initiated 
(methylprednisolone 500 mg for 5 days, gradually tapered to 16 mg every other day). Her 
condition stabilized and she had no new symptoms during the next 6 years on low-dose 
methylprednosolone every other day. Then she developed mental impairment, motor 
dysphasia and worsening of her right-sided hemiparesis. Repeat brain MRI revealed extensive 
white matter hyperintensities in the left temporal and parietal lobes, in the right cerebellar 
hemisphere and periventricularly bilaterally. Since then, her condition progressed despite 
corticosteroid therapy and a series of brain MRIs also showed progression of brain lesions 
(Figure 1 c-l). Throughout the period of illness, there were no signs of involvement of any 
organs other than the brain. Treatment with azathioprine 50 mg BID was tried, but the patient 
developed liver enzyme elevation and this therapy was discontinued. Cyclosporine therapy 
was suggested, but the patient refused it due to potential side effects. At the last control visit, 
the patient had severe cognitive impairment and tetraplegia. 
 
Discussion 
Our patient met the criteria for definitive diagnosis of neurosarcoidosis: clinical presentation 
compatible with neurosarcoidosis, exclusion of other possible causes and positive nervous 
system histology (2). However, the diagnosis of isolated neurosarcoidosis remains very 
difficult despite the established criteria. As it can affect any part of the nervous system, 
clinical presentation may range from headaches to altered consciousness and severe motor 
deficits. Some clinical presentations are often associated with a higher rate of morbidity and 
death. In contrast to an isolated mass lesion, which has a favorable outcome, poor outcome is 
associated with seizures, hydrocephalus, chronic meningitis and multifocal parenchymal 
disease (3). In our patient, the initial manifestation was partial motor seizure caused by the 
solitary mass lesion. This finding, along with later development of disseminated white matter 
disease, put this patient at a high risk of poor outcome. 
Mass lesions are frequently reported in patients with neurosarcoidosis and they may mimic 
primary or metastatic tumor or tumefacient demyelination (4,5). However, adjacent 
leptomeningeal involvement is frequently seen, a finding that may help reach an accurate 
diagnosis (5). These patients often present with seizures, which were a presenting feature in 
our patient, however, leptomeningeal involvement was absent. Later, when diffuse 
involvement of the white matter ensues, the lesions may be indistinguishable from those seen 
in multiple sclerosis.  
A typical and most common imaging feature in neurosarcoidosis is thickening and 
enhancement of basilar leptomeninges, followed by enhancing or nonenhancing parenchymal 
lesions and hydrocephalus (6). Imaging findings in neurosarcoidosis can mimic astrocytoma, 
meningioma, intracranial metastatic disease, CNS vasculitis, other granulomatous diseases 
such as tuberculosis, parasitic and fungal infections, and Wegener's or lymphomatous 
granulomatosis, and multiple sclerosis (7). If there is a known history of pulmonary 
sarcoidosis, the diagnosis of neurosarcoidosis is straightforward. However, when CNS 
involvement is a first manifestation, all the diseases mentioned above should be excluded. 
This makes neurosarcoidosis one of the great mimickers in neurology. The follow up of more 
than 21 years in the patient presented supports the existence of isolated neurosarcoidosis as a 
separate disease entity. 
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Figures  
Figure 1 
Series of brain MRIs performed during the 20-year period: a) 1986, FLAIR sequence; b) 
1990, T2 sequence; c) 1991, T2 sequence; d) 1992, FLAIR sequence; e) 1993, FLAIR 
sequence; f) 1994, FLAIR sequence; g) 1996; T2 sequence; h) 1997, T2 sequence; i) 1998, T2 
sequence; j) 2000, FLAIR sequence; k) and l) 2003,  FLAIR sequences. Note the progression 
of lesions as well as development of brain atrophy and ventriculomegaly.  
 
 
 
 
 
  
 
 
Figure 2 
a) Small meningeal granuloma with a large multinucleated giant cell; H&E; b) multiple 
granulomatous lesions in the cerebral white matter; H&E; c) parencymal granulomatous 
lesion in the white matter; H&E; d) higher magnification showing lymphocytes, plasma cells 
and a multinucleated giant cell; H&E; e) CD3 staining shows dense T-cell infiltrates in the 
periphery of the granuloma; immunocytochemistry for CD3; f) CD68 staining shows 
profound macrophage infiltrates, especially in the center; immunocytochemistry for CD 68; g) 
giant cells stained for CD68 (macrophages); immunocytochemistry for CD 68; h) small 
perivascular granuloma with multinucleated giant cell; immunocytochemistry for CD68; and 
i) plasma cells within the periphery of the granuloma stained for immunoglobulins; 
immunocytochemistry for immunoglobulins. 
 
